Date,Location,Topic
January 11th 2018,CEB,[ICH E9 Addendum](http://www.ich.org/ichnews/newsroom/read/article/ich-e9r1-revised-guideline-reaches-step-2b-of-the-ich-process.html) and [Per-Protocol Analyses of Pragmatic Trials](http://www.nejm.org/doi/full/10.1056/NEJMsm1605385?query=featured_clinical-trials)
February 8th 2018,Swiss TPH,[Estimands and Their Role in Clinical Trials](http://www.tandfonline.com/doi/full/10.1080/19466315.2017.1302358?af=R)
March 8th 2018,CEB,[A taxonomy of estimands for regulatory clinical trials with discontinuations](http://onlinelibrary.wiley.com/doi/10.1002/sim.6841/full)
April 12th 2018,Swiss TPH,[Estimands in clinical trials broadening the perspective](http://onlinelibrary.wiley.com/doi/10.1002/sim.7033/full) (possibly with comments)
May 17th 2018,CEB,[Multiple Endpoints in Clinical Trials: FDA Issues Draft Guidance](https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm536750.pdf) (Parts I to III)
June 14th 2018,Swiss TPH,[Multiple Endpoints in Clinical Trials: FDA Issues Draft Guidance](https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm536750.pdf) (Parts IV to V)